Altamira Therapeutics (CYTOF) Q3 2024 Earnings

24SepConfirmed
Q1 1
Q3 2024
-2.38
-1.77
-1.15
-0.54

Details

Expected EPS
-2.380322
Actual EPS
-1.9851696389
Surprise EPS
0.4
Surprise Percent
+16.6%

Description

Altamira Therapeutics (CYTOF) has reported earnings of -1.9851696389 per share for Q3 2024.

0 Comments

Share your thoughts